Ikesue, H., Mouri, M., Tomita, H., Hirabatake, M., Ikemura, M., Muroi, N., . . . Hashida, T. (2021). Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases. Support Care Cancer.
Chicago Style CitationIkesue, Hiroaki, et al. "Associated Characteristics and Treatment Outcomes of Medication-related Osteonecrosis of the Jaw in Patients Receiving Denosumab or Zoledronic Acid for Bone Metastases." Support Care Cancer 2021.
Cita MLAIkesue, Hiroaki, et al. "Associated Characteristics and Treatment Outcomes of Medication-related Osteonecrosis of the Jaw in Patients Receiving Denosumab or Zoledronic Acid for Bone Metastases." Support Care Cancer 2021.